a public good project by the
Synthesis
Company
of California

© 2026

Claudio Viscoli | doi.page

0 works0 citations0 h-index

Claudio Viscoli

Ospedale Policlinico San Martino(IT)

Publications by Year

Research Areas

Antifungal resistance and susceptibility, Neutropenia and Cancer Infections, Fungal Infections and Studies, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing

Most-Cited Works

→ Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group(2008)4,889 cited
→ Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium(2019)2,676 cited
→ Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline(2018)1,478 cited
→ ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients(2012)1,208 cited
→ Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy(2012)1,004 cited
→

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

(2019)

880 cited

→ ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients(2016)671 cited

→ European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia(2013)622 cited

→ Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)(1999)607 cited

→ Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial(2005)522 cited